AAPK-25 is a potent and selectiveAurora/PLKdual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3^Ser10phosphorylation and followed by a surge inapoptosis. AAPK-25 targets Aurora-A, -B, and -C withK_dvalues ranging from 23-289 nM, as well as PLK-1, -2, and -3 withK_dvalues ranging from 55-456 nM^[1].

Kd: 23 nM (Aurora-A), 78 nM (Aurora-B), 289 nM (Aurora-C), 55 nM (PLK-1), 272 nM (PLK-2), 456 nM (PLK-3), 5.32 μM (ERK), 7.11 μM (PI3K), 8.02 μM (CDK)^[1]

AAPK-25 inhibits HCT-116, Calu6, A549 and MCF-7 cells growth with IC₅₀s of 0.4, 5.3, 11.6, and 2.3 μM, respectively^[1].
AAPK-25 induces apoptosis as a dose-dependent manner in HCT-116 cell line^[1].
AAPK-25 has significantly increased histone H3^Ser10phosphorylation, indicating a markedly mitotic block^[1].
AAPK-25 is in notably inhibition of the mitotic spindle checkpoint, which is mainly mediated by cell cycle signaling and mitotic pathways^[1].

AAPK-25 enhances survival rate in the BALB/c nude mice tumor xenograft model^[1].

442.32

Solid

C₂₁H₁₃Cl₂N₃O₂S

2247919-28-2

Room temperature in continental US; may vary elsewhere.

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

DMSO : 50 mg/mL(113.04 mM;Need ultrasonic)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (protect from light)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。